24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825

Alzheimers Disease and other Cognitive Disorders
Resources
Basic Information
Introduction & Causes of Cognitive DisordersDementiaAlzheimer's DiseaseOther Cognitive DisordersDementia Coping Skills & Behavior ManagementTraumatic Brain Injury (TBI)Conclusion and Resources
More InformationLatest News
Targeting 9 Risk Factors Could Prevent 1 in 3 Dementia Cases: StudyAAIC: Rx + Training Shows Benefit in Advanced Alzheimer'sAAIC: Alzheimer Biomarkers Up With Sleep Disordered BreathingDozens of Potential Alzheimer's Meds in the PipelineSpecial Training Plus Medication Might Help People With Advanced Alzheimer'sOne Social Hour a Week Can Help Someone With DementiaSleep Problems: An Early Warning Sign of Alzheimer's?Severe Head Injury May Raise Dementia Risk Years LaterPPIs Not Found to Raise Risk of Alzheimer's DiseasePopular Heartburn Meds Don't Raise Alzheimer's Risk: StudyLifestyle Changes Might Prevent or Slow DementiaSevere Headaches Plague Vets With Traumatic Brain InjuriesSticky Brain 'Plaques' Implicated in Alzheimer's Again'Making the Best of It': Families Face the Heavy Burden of Alzheimer'sCognitive Decline Linked to Visual Field VariabilityAlzheimer's Deaths Jump 55 Percent: CDCLife Expectancy Slighter Shorter With Parkinson's, DementiaLow Body Mass Index Not Risk Factor for Alzheimer's DiseaseThin People Not More Prone to Alzheimer's, Study FindsWives, Daughters Shoulder Most of Alzheimer's Care BurdenGene Mutation May Speed Alzheimer's DeclineSilent Seizures May Contribute to Alzheimer's Pathology'Silent' Seizures Tied to Alzheimer's SymptomsPsychiatric Scars of Wartime Brain Injury May Linger for YearsMany Patients With Alzheimer's Disease Discontinue AChEIsMicrovascular Endothelial Dysfunction Can Predict DementiaAntipsychotic Medication Use Can Be Reduced in Dementia PatientsPast Psychiatric Disorders Do Not Raise Risk of Alzheimer's DiseasePast Psychiatric Ills Don't Raise Alzheimer's Risk: StudyXanax, Valium May Boost Pneumonia Risk in Alzheimer's PatientsSGA Prescribing Higher for Veterans With PTSD/DementiaDrug Tied to Dementia Risk Overprescribed to Seniors: StudyProton Pump Inhibitor Use Ups Pneumonia Risk in DementiaVitamin E, Selenium Supplements Won't Curb Men's Dementia RiskDizzy Spells in Middle-Age Tied to Dementia Risk LaterFive Million American Seniors Now Living With Alzheimer'sStudy: Gene Test Needed Before Using Alzheimer's Drug 'Off-Label'Annual Death Toll From Alzheimer's Nearly Doubles in 15 YearsImmune Disorders Such as MS, Psoriasis May Be Tied to Dementia RiskIs Need for More Sleep a Sign of Pending Dementia?Unhealthy in Middle Age, Dementia in Old Age?HRT Won't Lower Women's Alzheimer's Risk, Study FindsReview Links Albuminuria to Cognitive Impairment, DementiaCan Air Pollution Heighten Alzheimer's Risk?Bilingual People May Have an Edge Against Alzheimer'sBusy Minds May Be Better at Fighting DementiaDementia May Be Exacerbated by Hospital-Related DeliriumLink Seen Between Concussions and Alzheimer'sContinuing Warfarin Protective After Diagnosis of DementiaDoes Living Near Major Roads Boost Dementia Risk?
Questions and AnswersLinks
Related Topics

Gene Mutation May Speed Alzheimer's Decline

HealthDay News
by -- Robert Preidt
Updated: May 3rd 2017

new article illustration

WEDNESDAY, May 3, 2017 (HealthDay News) -- A gene mutation seems to speed up the loss of memory and thinking skills in people with Alzheimer's disease, new research suggests.

Researchers said the gene mutation -- called BDNF Val66Met allele, or the Met allele -- was pinpointed by following more than 1,000 people who were at risk of developing Alzheimer's disease. The researchers followed them for 13 years. The participants' average age was 55 at the start of the study.

Blood samples were tested for the gene mutation. Memory and thinking abilities were tested at the start of the study and at up to five visits during the study period.

The 32 percent of participants with the Met allele lost memory and thinking skills more rapidly than those without the gene mutation, the findings showed. The decline was even quicker among those with both the Met allele and higher levels of beta-amyloid, a sticky protein that can form plaques in the brains of people with Alzheimer's disease.

The BDNF gene normally produces a protein that helps nerve cells grow, specialize and survive.

"Because this gene can be detected before the symptoms of Alzheimer's start, and because this presymptomatic phase is thought to be a critical period for treatments that could delay or prevent the disease, it could be a great target for early treatments," said study author Ozioma Okonkwo of the University of Wisconsin School of Medicine.

"When there is no mutation, it is possible the BDNF gene and the protein it produces are better able to be protective, thereby preserving memory and thinking skills," Okonkwo said in a news release from the American Academy of Neurology.

"This is especially interesting because previous studies have shown that exercise can increase levels of BDNF. It is critical for future studies to further investigate the role that the BDNF gene and protein have in beta-amyloid accumulation in the brain," Okonkwo concluded.

The study was published online May 3 in the journal Neurology.

More information

The U.S. Department of Health and Human Services has more about Alzheimer's disease.